DF
CORT icon

DecisionPoint Financial’s Corcept Therapeutics CORT Stock Holding History

DecisionPoint Financial’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$974 Hold
11
– – ﹤0.01% 453
2026
Q1 		$444 Hold
11
– – ﹤0.01% 504
2025
Q4 		$383 Hold
11
– – ﹤0.01% 589
2025
Q3 		$927 Hold
11
– – ﹤0.01% 345
2025
Q2 		$763 Buy
+11
New +$798 ﹤0.01% 363

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DecisionPoint Financial's CORT Position: Q2 2026 in Review

DecisionPoint Financial held its Corcept Therapeutics (CORT) position steady in Q2 2026 at 11 shares worth $974. The position accounts for ﹤0.01% of the portfolio, ranked #453.

DecisionPoint Financial first reported a position in CORT in Q2 2025 and has held it in 5 quarters since. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • DecisionPoint Financial held 11 shares of Corcept Therapeutics worth $974 as of Q2 2026.
  • DecisionPoint Financial left its Corcept Therapeutics share count unchanged in Q2 2026.
  • Corcept Therapeutics made up ﹤0.01% of DecisionPoint Financial's portfolio in Q2 2026, its #453 holding.
  • DecisionPoint Financial first reported a position in Corcept Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on DecisionPoint Financial's 13F filing for Q2 2026, filed 5 Aug 2026.